Scott Filosi is the Senior Vice President of Managed Markets. Mr. Filosi has more than 20 years of healthcare experience in increasingly senior positions, with a focus on managed markets, global business development, and market access for biologics.
Most recently, Mr. Filosi was the Head of US Market Access and Pricing and the Head of Established Brands in the US, and Managing Director for Canada and Mexico at UCB Pharma. In this role, he had full P&L responsibility for the Established Brands and led contracting, access, distribution, reimbursement, access strategy, health outcomes, channel forecasting and gross to net for the US.
Previous to UCB, Mr. Filosi was Vice President of Global Business Development at i3 Innovus, where he helped to create and lead US and EU business development model design and implementation for health outcomes. Prior to joining i3 Innovus, Mr. Filosi spent six years with Boehringer Ingelheim and 13 years with Johnson & Johnson.
Mr. Filosi holds a BS in Marketing and Business Administration from University of Massachusetts.